naloxone hydrochloride
naloxone hydrochloride is listed in the FDA National Drug Code directory with 22 NDC codes, marketed under brand names including NALOXONE HYDROCHLORIDE, RiVive, Naloxone Hydrochloride. Available dosage forms: injection, solution, spray, injection.
Drug Details
- Generic Name
- naloxone hydrochloride
- Brand Names
- NALOXONE HYDROCHLORIDE, RiVive, Naloxone Hydrochloride, naloxone hydrochloride
- Application Number
- ANDA218404
- Sponsor
- Henry Schein, Inc.
- NDC Codes
- 22
- Dosage Forms
- INJECTION, SOLUTION, SPRAY, INJECTION
- Routes
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, NASAL, PARENTERAL
- Active Ingredients
- NALOXONE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablets contain buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and are indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )